It is a trading private limited company based in New Elhi, Delhi, India, established in 2015.
2015 | New Elhi, Delhi, India | ActiveRitesource Pharma Solutions Private Limited, a active private limited company, was established on 30 December 2015 in New Elhi, Delhi, India. Engaging in wholesale within the trade sector, it holds CIN: U24240DL2015PTC289037. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sunil Yadav (Director), Shagun (Director). Past directors included Sunil Yadav, Shagun, Punita Sharma. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at H. No. 201, Kakrola Housing Complex, Kakrola Mod, New Elhi, Delhi, 110078.
U24240DL2015PTC289037
289037
30 December 2015
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Ritesource Pharma Solutions Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Yadav | Director | 01 Apr 2017 | Current |
| Shagun | Director | 29 Apr 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 01 Apr 2017 | Past |
| Pramod Abcsdd | Director | 01 Apr 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ritesource Pharma Solutions Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 92.65% increase in profit. The company's net worth dipped by a decrease of 1.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Ritesource Pharma Solutions had a promoter holding of 34.00% and a public holding of 66.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ritesource Pharma Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ritesource Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ritesource Pharma Solutions's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ritesource Pharma Solutions Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
The activity Ritesource Pharma Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi. was completed.
Sunil Yadav was appointed as a Director was appointed as a Director on 01 Apr 2017 & has been associated with this company since 8 years 8 months . was recorded as a recent event.
Shagun was appointed as a Director was appointed as a Director on 29 Apr 2016 & has been associated with this company since 9 years 7 months . was recorded as a recent event.
Progress on Ritesource Pharma Solutions Private Limited was registered on 30 Dec 2015 with Roc Delhi & aged 9 years 11 months as per MCA records. was documented.
The CIN of Ritesource Pharma Solutions Private Limited is U24240DL2015PTC289037.
Ritesource Pharma Solutions Private Limited is headquartered at H. No. 201, Kakrola Housing Complex, Kakrola Mod, New Elhi, Delhi, 110078.
Ritesource Pharma Solutions Private Limited was incorporated on 30 December 2015.
The current directors of Ritesource Pharma Solutions Private Limited are
The primary industry of Ritesource Pharma Solutions Private Limited is Trade.
Ritesource Pharma Solutions Private Limited is unlisted.
The authorized capital of Ritesource Pharma Solutions Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Ritesource Pharma Solutions Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX